|
|
||||||||
hang
r Uyan
ik
kmet BayhanDepartments of Nuclear Medicine and Cardiology, Gülhane Military Medical Academy and Faculty, Ankara, Turkey
Correspondence: For correspondence or reprints contact: Bengül Günalp, MD, Gülhane Askeri Tip Akademisi, Nükleer Tip Anabilim Dali, 06018 Etlik Ankara, Turkey.
ABSTRACT
The value of dobutamine echocardiography and 99mTc-sestamibi SPECT imaging was evaluated as a noninvasive diagnostic method for assessing coronary artery disease (CAD).Twenty-seven patients who underwent coronary angiography were submitted to two separate injections of 99mTc-sestamibi, one under control conditions and the other after reaching a peak dobutamine infusion rate. Simultaneous ECG and echocardiographic monitoring was also performed during stepwise dobutamine infusion. Whereas the overall sensitivity and specificity of dobutamine sestamibi SPECT imaging were 94% and 88%, these values for dobutamine ECG and echocardiography were 61%, 55% and 84%, 88%, respectively. When dobutamine echocardiography and 99mTc-sestamibi SPECT imaging were evaluated together, the diagnostic accuracy reaches almost 100%. Dobutamine echocardiography is of value in determining ischemic threshold earlier than clinical symptoms and allows simultaneous evaluation of ventricular performance and contractile function associated with perfusion abnormalities on 99mTc-sestamibi SPECT imaging. Our experience shows that 99mTc-sestamibi SPECT imaging, when combined with dobutamine echocardiography, is a safe, practical, well tolerated method with high diagnostic accuracy for the evaluation of CAD.
This article has been cited by other articles:
![]() |
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharma and S. J Brecker Dobutamine stress echocardiography in diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1): 42 - 46. [Abstract] [PDF] |
||||
![]() |
C Y Loong and C Anagnostopoulos Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging Heart, August 1, 2004; 90(suppl_5): v2 - v9. [Full Text] [PDF] |
||||
![]() |
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography) J. Am. Coll. Cardiol., September 3, 2003; 42(5): 954 - 970. [Full Text] [PDF] |
||||
![]() |
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation, September 2, 2003; 108(9): 1146 - 1162. [Full Text] [PDF] |
||||
![]() |
A.F.L Schinkel, J.J Bax, M.L Geleijnse, E Boersma, A Elhendy, J.R.T.C Roelandt, and D Poldermans Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur. Heart J., May 1, 2003; 24(9): 789 - 800. [Full Text] [PDF] |
||||
![]() |
A. Elhendy, J. J. Bax, and D. Poldermans Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Lancellotti, T Benoit, P Rigo, and L A Pierard Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction Heart, November 1, 2001; 86(5): 510 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt Dobutamine stress myocardial perfusion imaging J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés Selection of the optimal stress test for the diagnosis of coronary artery disease Heart, October 1, 1998; 80(4): 370 - 376. [Abstract] [Full Text] |
||||
![]() |
D. A. Calnon, D. K. Glover, G. A. Beller, G. Vanzetto, W. H. Smith, D. D. Watson, and M. Ruiz Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses : Implications for Dobutamine Stress Testing Circulation, October 7, 1997; 96(7): 2353 - 2360. [Abstract] [Full Text] |
||||
![]() |
M. L. Geleijnse, A. Elhendy, R. T. van Domburg, J. H. Cornel, R. Rambaldi, A. Salustri, A. E. M. Reijs, J. R. T. C. Roelandt, and P. M. Fioretti Cardiac Imaging for Risk Stratification With Dobutamine-Atropine Stress Testing in Patients With Chest Pain : Echocardiography, Perfusion Scintigraphy, or Both? Circulation, July 1, 1997; 96(1): 137 - 147. [Abstract] [Full Text] |
||||
![]() |
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |